Therapeutic Strategies to Overcome ALK Resistance in Cancer
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 20)

H-INDEX

(FIVE YEARS 0)

Published By Elsevier

9780128217740

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

The ALK receptor tyrosine kinase journey: From physiological roles to pathological disruptions

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00010-3 ◽

2021 ◽

pp. 1-29

Author(s):

Fabrizio Tabbò ◽

Luisella Righi ◽

Riccardo Taulli ◽

Silvia Novello

Keyword(s):

Tyrosine Kinase ◽

Receptor Tyrosine Kinase

Download Full-text

Contributors

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.09986-1 ◽

2021 ◽

pp. xix

Author(s):

Sylvain Baruchel ◽

María Castro-Henriques ◽

Ana Collazo-Lorduy ◽

Marie-Emilie Dourthe ◽

Francesco Facchinetti ◽

...

Download Full-text

Index

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.09987-3 ◽

2021 ◽

pp. 191-195

Download Full-text

Resistance mechanisms to ALK TKIs in tumors other than lung cancer

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00005-x ◽

2021 ◽

pp. 101-121

Author(s):

Luca Mologni

Keyword(s):

Lung Cancer ◽

Resistance Mechanisms

Download Full-text

Systemic treatments other than TKI: Reflections on chemotherapy, immunotherapy and antiangiogenic agents in ALK-driven NSCLC

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00014-0 ◽

2021 ◽

pp. 55-69

Author(s):

Alessandro Leonetti ◽

Marcello Tiseo

Keyword(s):

Antiangiogenic Agents ◽

Systemic Treatments

Download Full-text

Therapeutic strategies to overcome ALK resistance in lung cancer

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00004-8 ◽

2021 ◽

pp. 123-139

Author(s):

Gonzalo Recondo ◽

Luc Friboulet

Keyword(s):

Lung Cancer ◽

Therapeutic Strategies

Download Full-text

About the Volume Editor

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00017-6 ◽

2021 ◽

pp. xiii

Keyword(s):

Volume Editor

Download Full-text

About the Series Editor

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00001-2 ◽

2021 ◽

pp. ix-x

Keyword(s):

Series Editor

Download Full-text

Therapeutic strategies to enhance crizotinib anti-tumor efficacy in ALK + ALCL

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00012-7 ◽

2021 ◽

pp. 141-159

Author(s):

Robert E. Hutchison

Keyword(s):

Therapeutic Strategies

Download Full-text

Preface

Therapeutic Strategies to Overcome ALK Resistance in Cancer ◽

10.1016/b978-0-12-821774-0.00018-8 ◽

2021 ◽

pp. xv

Author(s):

Ken A. Olaussen

Download Full-text

Therapeutic Strategies to Overcome ALK Resistance in CancerLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

The ALK receptor tyrosine kinase journey: From physiological roles to pathological disruptions

Contributors

Index

Resistance mechanisms to ALK TKIs in tumors other than lung cancer

Systemic treatments other than TKI: Reflections on chemotherapy, immunotherapy and antiangiogenic agents in ALK-driven NSCLC

Therapeutic strategies to overcome ALK resistance in lung cancer

About the Volume Editor

About the Series Editor

Therapeutic strategies to enhance crizotinib anti-tumor efficacy in ALK + ALCL

Preface

Therapeutic Strategies to Overcome ALK Resistance in Cancer
Latest Publications